[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 POC/Decentralized Infectious Disease Testing Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers-- Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies

May 2016 | 835 pages | ID: 28F76CACAF8EN
Venture Planning Group

US$ 6,800.00 US$ 8,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 835-page report from VPGMarketResearch.com contains 80 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R D and marketing strategies for the global POC infectious disease testing market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis
  • Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers
  • Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
    • Physician Offices/Group Practices
    • Emergency Rooms
    • Ambulatory Care Centers
    • Surgery Centers - Birth Centers
Sales and Market Share Analysis- Market shares of major infectious disease diagnostic reagent and instrument suppliers.Current and Emerging Products- Analysis of infectious disease diagnostic tests performed in POC testing locations.- Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.Technology Review- Emerging technologies and their applications for POC testing.- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.Competitive Assessments- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R D.Strategic Recommendations- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.- Design criteria for POC testing products.- Alternative business expansion strategies.
  • Potential market entry barriers and risks.MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

    Contains 835 pages and 80 tables
  • INTRODUCTION

    Executive Summary
    Rationale for Testing Decentralization
      1. OVERVIEW
      2. REGULATORY TRENDS
      3. ECONOMIC TRENDS
      4. DEMOGRAPHIC TRENDS
      5. TECHNOLOGICAL TRENDS
      6. SOCIAL TRENDS
      7. QUALITY OF CARE
      8. DEFENSIVE MEDICINE
      9. QUALITY CONTROL ISSUES

    WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

      1. AIDS
      2. ADENOVIRUS
      3. CAMPYLOBACTER
      4. CANDIDA
      5. CHLAMYDIA
      6. CLOSTRIDIUM DIFFICILE
      7. CYTOMEGALOVIRUS
      8. ENTEROVIRUSES
      9. EPSTEINBARR VIRUS
      10. GONORRHEA
      11. HELICOBACTER PYLORI
      12. HEPATITIS
        a. Hepatitis A
        b. Hepatitis B
        c. Hepatitis C
        d. Hepatitis D
      13. HERPES SIMPLEX VIRUS
      14. HUMAN HERPES VIRUS    6 (HHV    6)
      15. INFLUENZA VIRUSES
      16. LEGIONELLA
      17. LYME DISEASE
      18. MEASLES (RUBEOLA)
      19. MENINGITIS
      20. MONONUCLEOSIS
      21. MUMPS
      22. MYCOPLASMA
      23. PAPILLOMAVIRUSES
      24. PNEUMONIA
      25. RESPIRATORY SYNCYTIAL VIRUS (RSV)
      26. RHEUMATOID ARTHRITIS
      27. ROTAVIRUS (REOVIRUS)
      28. RUBELLA (GERMAN MEASLES)
      29. SALMONELLOSIS
      30. SHIGELLOSIS
      31. STAPHYLOCOCCUS AUREUS
      32. STREPTOCOCCI
      33. SYPHILIS
    Instrumentation: Infectious Disease Analyzers Manufactured by : Abbott
      Beckman Coulter/Danaher
      bioMeriuex
      Ortho    Clinical Diagnostics
      Roche
      Siemens
      Tosoh
      Wallac, and other suppliers
    Current and Emerging Technologies
      1. MONOCLONAL ANTIBODIES
      2. IMMUNOASSAYS
        a. Technological Principle
        b. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          Dot Immunobinding Assays
          Capillary Immunoassays
          Particle Membrane Capture Immunoassay
          Enzyme Amplification
        c. Fluorescent Immunoassays
          Fluorescent Polarization
          Time Resolved Pulse Fluorescence
        d. Luminescence
          Chemiluminescence
          Bioluminescence
        e. Latex Agglutination
        f. Immunoprecipitation
      3. DRY CHEMISTRY
      4. BIOSENSORS
      5. IT AND AUTOMATION
      6. MOLECULAR DIAGNOSTICS
        a. Technology Overview
        b. Amplification Methods
          Polymerase Chain Reaction
          Ligase Chain Reaction
          Branched DNA
          Q    Beta Replicase
          Strand Displacement Activation
          Self    Sustained Sequence Replicase

    U.S.A.

    A. Market Overview
      1. BUSINESS ENVIRONMENT
        a. Health Care Expenditures
        b. Cost Consciousness
        c. Reimbursement
        d. Industry Consolidation
        e. Managed Care
          PPO

          HMO

        f. Hospitals
        g. Admissions
        h. Length of Stay
        i. Industry Diversification
        j. Physician Demographics
        k. Aging Population
          More Chronic Illness
          Disease Incidence
          Susceptibility to latrogenesis
          Multiple Illnesses Cases
        l. Laboratory Regulations
      2. MARKET STRUCTURE
        a. Hospitals
        b. Commercial/Private Laboratories
    C. Physician Offices/Group Practices

    1. MARKET SUMMARY

      2. MARKET STRUCTURE
      3. TEST VOLUME AND SALES FORECASTS
    D. Ancillary Hospital Locations
      1. INTRODUCTION
        a. Emergency Departments   b. Operating Suites
        c. Intensive Care Units
      2. EMERGENCY DEPARTMENTS A. MARKET SUMMARY
        b. Test volume and Sales Forecasts
      3. OPERATING AND RECOVERY SUITES A. MARKET SUMMARY
        b. Test Volume and Sales Forecasts
      4. ICUS/CCUS
        a. Market Summary
        b. Test Volume and Sales Forecasts
    E. Cancer Clinics
      1. INTRODUCTION
      2. MARKET SUMMARY
      3. TEST VOLUME AND SALES FORECASTS
    F. Ambulatory Care Centers

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    G. Surgery Centers

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    H. Nursing Homes

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS

    1. BIRTH CENTERS

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    J. Major Suppliers’ Instrument Placements, Installed Base, Reagent Sales and Market Shares
    Germany
    A. Market Overview
    B. Market Structure
    C. Market Summary
    D. Major Suppliers’ Reagent Sales and Market Shares
    Spain
    A. Business Environment
    B. Market Structure
    C. Market Summary
    D. Major Suppliers’ Reagent Sales and Market Shares
    Major Product Development Opportunities

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. MARKETING APPROACHES
      2. PRODUCT COMPLEXITY
      3. CUSTOMER PREFERENCE
      4. ESTABLISHED SUPPLIERS
      5. EMERGING SUPPLIERS
      6. MAJOR TYPES OF DISTRIBUTORS
      7. MARKET SEGMENTATION

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Company Profile
      Abbott
      ADI/American Diagnostica
      Agilent Technologies
      Alere/Biosite/Inverness
      Axis    Shield
      Beckman Coulter/Danaher
      Becton Dickinson
      Bio/Data
      Biomerieux
      Bio-Rad
      Cepheid
      Chrono    Log
      Corgenix
      Decode Genetics
      Diadexus
      Diagnocure
      Diagnostica Stago/Trinity Biotech
      Diamedix
      Diasorin
      Eiken Chemical
      EKF Diagnostics
      Fujirebio
      Grifols
      Helena Laboratories
      Hologic/Genrobe
      Horiba
      Instrumentation Laboratory
      International Technidyne/Nexus DX
      Kreatech/Leica
      Kyowa Medex
      Lonza
      Mackay Life Sciences
      Matritech
      Nihon Kohden
      Ortho    Clinical Diagnostics
      Polartechnics
      Polymedco
      Qiagen
      Roche
      SDIX
      Sequenom
      Siemens
      Sienco
      Sysmex
      Takara Bio
      ThermoFisher
      Tosoh
      Wako
      Zycare/Alere

    LIST OF TABLES

    Major Companies Developing or Marketing AIDS Tests
    Major Companies Developing or Marketing Adenovirus Tests
    Major Companies Developing or Marketing Campylobacter Tests
    Major Companies Developing or Marketing Candida Tests
    Major Companies Developing or Marketing CMV Tests
    Major Companies Developing or Marketing EBV Tests
    Major Companies Developing or Marketing Gonorrhea Tests
    Major Companies Developing or Marketing Helicobacter Pylori Tests
    Major Companies Developing or Marketing Hepatitis Tests
    Major Companies Developing or Marketing Herpes Tests
    Major Companies Developing or Marketing Influenza Tests
    Major Companies Developing or Marketing Legionella Tests
    Major Companies Developing or Marketing Lyme Disease Tests
    Major Companies Developing or Marketing Measles Tests
    Major Companies Developing or Marketing Meningitis Tests
    Major Companies Developing or Marketing Mononucleosis Tests
    Major Companies Developing or Marketing Mumps Tests
    Major Companies Developing or Marketing Mycoplasma Tests
    Major Companies Developing or Marketing Pneumonia Tests
    Major Companies Developing or Marketing RSV Tests
    Major Companies Developing or Marketing Rotavirus Tests
    Major Companies Developing or Marketing Rubella Tests
    Major Companies Developing or Marketing Salmonella Tests
    Major Companies Developing or Marketing Shigella Tests
    Major Companies Developing or Marketing Streptococci Tests
    Major Companies Developing or Marketing Syphilis Tests
    U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
    U.S.A., Physician Offices/Group Practices Forecast by Type
    U.S.A., Office Based Physicians Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
    U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
    U.S.A., Ancillary Hospital Locations Estimated Number
    U.S.A., Ancillary Hospital Locations Annual Utilization
    U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
    U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
    U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
    U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
    U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
    U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
    U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
    U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
    U.S.A., Surgery Centers Most Frequently Performed Procedures
    U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
    U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
    U.S.A., Birth Centers Facilities, Patient Visits, and Births
    U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
    U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
    U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
    Germany, Laboratory Performing Diagnostic Tests by Market Segment
    Germany, AIDS Testing Market Estimated Market Share of Major Suppliers
    Germany, Gonorrhea Testing Market Estimated Market Share of Major Suppliers
    Germany, Hepatitis Testing Market Estimated Market Share of Major Suppliers
    Germany, Herpes Testing Market Estimated Market Share of Major Suppliers
    Germany, Influenza Testing Market Estimated Market Share of Major Suppliers
    Germany, Mononucleosis Testing Market Estimated Market Share of Major Suppliers
    Germany, Septicemia Testing Market Estimated Market Share of Major Suppliers
    Germany, Streptococci Testing Market Estimated Market Share of Major Suppliers
    Spain, Laboratory Performing Infectious Disease Tests by Market Segment
    Spain, AIDS Testing Market Estimated Market Shares of Major Suppliers
    Spain, Chlamydia Testing Market Estimated Market Shares of Major Suppliers
    Spain, Hepatitis Testing Market Estimated Market Shares of Major Suppliers
    Spain, Herpes Testing Market Estimated Market Shares of Major Suppliers
    Spain, Influenza Testing Market Estimated Market Shares of Major Suppliers
    Spain, Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
    Spain, Rubella Testing Market Estimated Market Shares of Major Suppliers
    Spain, Streptococci Testing Market Estimated Market Shares of Major Suppliers
    Spain, Syphilis Testing Market Estimated Market Shares of Major Suppliers


    More Publications